Therefore, we speculated that the inhibition of CDK4 inhibitor on the cell viability of P-Tex cells (which were beneficial to the survival prognosis of HPV-positive HNSCC patients) might be a potential reason why CDK4 inhibitors were ineffective in treating HPV-positive HNSCC patients. Here, CDK4 is linked to head and neck squamous cell carcinoma.